Bausch + Lomb Announces Launch of IPO

Bausch + Lomb announced the launch of its initial public offering (IPO) and the commencement of the roadshow for the IPO. Bausch + Lomb, which is being spun out of Bausch Health, plan to sell 35 million common shares for $21 to $24 per share, for a valuation of as much $8.4 billion.

Bausch Health intends to grant the underwriters a 30-day option to purchase up to an additional 5.25 million common shares of Bausch + Lomb to cover over-allotments, if any.

Bausch + Lomb has applied to list its common shares on the New York Stock Exchange (NYSE) and the Toronto Stock Exchange (TSX) under the ticker symbol "BLCO."

Following the IPO, Bausch Health, together with its subsidiaries, is expected to hold approximately 90% of the common shares of Bausch + Lomb, or 88.5% of the common shares of Bausch + Lomb if the underwriters' over-allotment option is exercised in full.